BioClinica

About:

BioClinica provides integrated, technology-enhanced clinical trial management solutions.

Website: http://www.bioclinica.com

Twitter/X: bioclinica

Top Investors: SV Health Investors

Description:

BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. BioClinica services maximize efficiency and manageability throughout all phases of the clinical trial process. With more than 20 years of experience and over 2,000 successful trials to date, BioClinica has supported the clinical development of many new medicines from early phase trials through final approval. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on two continents, and supports worldwide eClinical and data management services from offices in the United States, Europe and Asia.

Total Funding Amount:

$13.7M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Newtown, Pennsylvania, United States

Founded Date:

1998-01-01

Contact Email:

general(AT)bioclininca.com

Founders:

Trevor McCaw

Number of Employees:

1001-5000

Last Funding Date:

2013-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai